Literature DB >> 23468581

Unsuspected pulmonary thromboemboli: a continuing clinical challenge.

Herbert L Fred.   

Abstract

The multidetector computed tomographic scanner has greatly improved our ability to quickly, safely, and adequately visualize the pulmonary arteries down to and including the subsegmental branches. But this sophisticated machine has also created new problems for clinicians who must care for patients who have what we now variously call incidental, asymptomatic, or unsuspected pulmonary thromboemboli—emboli that are clinically silent and detected unexpectedly. At this stage of our knowledge, we can say with certainty that these thromboemboli are common in all parts of the pulmonary arterial tree, are most often found in patients with cancer, carry a poor prognosis for patients with cancer, and are frequently missed during the initial CT reading. Their natural history and optimal management await definitive studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23468581      PMCID: PMC3568269     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  53 in total

1.  Drawbacks and limitations of computed tomography: views from a medical educator.

Authors:  Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2004

2.  Unsuspected pulmonary embolism on CT scanning: yet another headache for clinicians?

Authors:  Sujal R Desai
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

Review 3.  Acute pulmonary embolism.

Authors:  Victor F Tapson
Journal:  N Engl J Med       Date:  2008-03-06       Impact factor: 91.245

Review 4.  Management of suspected acute pulmonary embolism in the era of CT angiography: a statement from the Fleischner Society.

Authors:  Martine Remy-Jardin; Massimo Pistolesi; Lawrence R Goodman; Warren B Gefter; Alexander Gottschalk; John R Mayo; H Dirk Sostman
Journal:  Radiology       Date:  2007-09-11       Impact factor: 11.105

5.  Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance.

Authors:  Casey L O'Connell; William D Boswell; Vinay Duddalwar; Amy Caton; Lisa S Mark; Cheryl Vigen; Howard A Liebman
Journal:  J Clin Oncol       Date:  2006-10-20       Impact factor: 44.544

6.  Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT.

Authors:  Carmel G Cronin; Derek G Lohan; Maccon Keane; Clare Roche; Joseph M Murphy
Journal:  AJR Am J Roentgenol       Date:  2007-07       Impact factor: 3.959

7.  Pulmonary embolism after injury: more common than we think?

Authors:  Jay Menaker; Deborah M Stein; Thomas M Scalea
Journal:  J Trauma       Date:  2009-12

8.  64-Multidetector-row spiral CT in pulmonary embolism with emphasis on incidental findings.

Authors:  Christian Sohns; Erick Amarteifio; Samuel Sossalla; Markus Heuser; Silvia Obenauer
Journal:  Clin Imaging       Date:  2008 Sep-Oct       Impact factor: 1.605

9.  Incidence of early pulmonary embolism after injury.

Authors:  Jay Menaker; Deborah M Stein; Thomas M Scalea
Journal:  J Trauma       Date:  2007-09

10.  The prevalence of symptomatic and coincidental pulmonary embolism on computed tomography.

Authors:  Gladwin C Hui; Alan Legasto; Conrad Wittram
Journal:  J Comput Assist Tomogr       Date:  2008 Sep-Oct       Impact factor: 1.826

View more
  2 in total

1.  Fate of newly developed pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus.

Authors:  Sangjun Yoo; Sang Hoon Song; Heounjeong Go; Dalsan You; Cheryn Song; Jun Hyuk Hong; Choung-Soo Kim; Hanjong Ahn; In Gab Jeong
Journal:  Int Urol Nephrol       Date:  2017-04-11       Impact factor: 2.370

2.  Contrast enhanced chest-MDCT in oncologic patients. Prospective evaluation of the prevalence of incidental pulmonary embolism and added value of thin reconstructions.

Authors:  Silvia Tresoldi; Nicola Flor; Andrea Luciani; Maria Antonietta Lombardi; Bernardo Colombo; Gianpaolo Cornalba
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.